Clinical Trial Update: Safety and Efficacy Study of Autologous Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating autologous bone marrow-derived stem cell treatment for amyotrophic lateral sclerosis has completed with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Autologous bone marrow derived stem cell treatment

Snippet

Sponsor: Corestemchemon, Inc. | Conditions: Amyotrophic Lateral Sclerosis, ALS | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-07-20